United Kingdom Bispecific Antibodies Market Size & Outlook, 2025-2031
United Kingdom Bispecific Antibodies Market Size
According to Straits Research analysis, the United Kingdom Bispecific Antibodies Market was valued at USD 209.95 Million in 2024 and is projected to reach USD 549.67 Million by 2031, expanding at a CAGR of 15.6% during the forecast period. This growth is largely driven by their applications in the healthcare industry, predominantly in cancer and autoimmune diseases treatment. Industries like biopharmaceuticals are capitalising on advances in bispecific antibodies for innovative therapeutics solutions, propelling market growth. Sustainable production tactics and technological advancements in antibody engineering are unfolding new opportunities. The rising export potential further fuels the growth of this market. As healthcare continues to be a pivotal sector in the UK, its firm dedication to biomedical research signifies its strategic positioning in the Bispecific Antibodies Market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Bispecific Antibodies Market Highlights
- By segment, Bi-specific T-cell engager emerged as the largest Type in terms of market size in 2024.
- Bi-specific T-cell engager is anticipated to remain the most attractive Type segment, recording the fastest growth during the forecast period.
- As of 2024, United Kingdom held 3.81% of the global bispecific antibodies market size.
- By 2031, United States is anticipated to capture the largest share of the global bispecific antibodies market.
- In Europe, Germany is expected to lead the regional bispecific antibodies market size by 2031.
- Germany will remain the fastest-growing market in Europe, reaching USD 398.46 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 209.95 Million |
| Market Size In 2031 | USD 549.67 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 15.6% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Kingdom Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
United Kingdom Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
United Kingdom Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
